Kristine Peterson

Kristine Peterson

Direktor/Vorstandsmitglied bei ENANTA PHARMACEUTICALS, INC.

Vermögen: 225 432 $ am 31.10.2026

66 Jahre
Health Technology
Commercial Services
Consumer Services

Profil

Kristine Peterson is currently an Independent Director at Enanta Pharmaceuticals, Inc. since 2017, Director at Greater Philadelphia Life Sciences Congress, Director at AFYX Therapeutics AS, Independent Non-Executive Director at Immunocore Holdings Plc since 2017, Non-Executive Director at Immunocore Ltd., Lead Independent Director at Arrivent BioPharma, Inc. starting 2025, and Independent Director at Mineralys Therapeutics, Inc. starting 2026.
Former roles include Chief Executive Officer at Valeritas Holdings, Inc. from 2009 to 2016, Chief Executive Officer & Director at Valeritas, Inc. from 2009 to 2016, Group Chairman-Biotech Group at Johnson & Johnson from 2006 to 2009, Independent Director at ImmunoGen, Inc. from 2012 to 2024, Independent Non-Executive Director at Amarin Corp.
Plc from 2010 to 2023, Director at Biotechnology Innovation Organization, Independent Non-Executive Director at EyePoint, Inc. from 2017 to 2020, Independent Director at Paratek Pharmaceuticals, Inc. from 2016 to 2023, Principal at Bristol Myers Squibb Co., President & Senior VP-Commercial Operations at Biovail Corp.
from 2003 to 2004, and President at Biovail Pharmaceuticals LLC from 2003 to 2004.
Education includes an undergraduate degree in 1981 and an MBA in 1983 from the University of Illinois At Urbana–Champaign.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
19.10.2026 12’400 ( 0.02% ) 225 432 $ 31.10.2026
27.05.2026 0 ( -.--% ) - $ 31.10.2026
18.06.2026 0 ( -.--% ) - $ 31.10.2026
11.03.2026 0 ( -.--% ) - $ 31.10.2026

Aktive Positionen von Kristine Peterson

UnternehmenPositionBeginn
ENANTA PHARMACEUTICALS, INC. Direktor/Vorstandsmitglied 13.09.2017
IMMUNOCORE HOLDINGS PLC Direktor/Vorstandsmitglied 01.11.2017
ARRIVENT BIOPHARMA, INC. Direktor/Vorstandsmitglied 20.04.2024
MINERALYS THERAPEUTICS, INC. Direktor/Vorstandsmitglied 19.10.2026
Greater Philadelphia Life Sciences Congress
Direktor/Vorstandsmitglied 08.04.2011
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -

Ehemalige bekannte Positionen von Kristine Peterson

UnternehmenPositionEnde
IMMUNOGEN, INC. Direktor/Vorstandsmitglied 12.02.2024
PARATEK PHARMACEUTICALS, INC. Direktor/Vorstandsmitglied 21.09.2023
░░░░░░ ░░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Kristine Peterson im Detail an

Ausbildung von Kristine Peterson

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

65

Beziehungen ersten Grades

19

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen19

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Greater Philadelphia Life Sciences Congress

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Börse
  2. Insider
  3. Kristine Peterson